CN104644949A - Medicine for treating osteoproliferation - Google Patents
Medicine for treating osteoproliferation Download PDFInfo
- Publication number
- CN104644949A CN104644949A CN201510126758.4A CN201510126758A CN104644949A CN 104644949 A CN104644949 A CN 104644949A CN 201510126758 A CN201510126758 A CN 201510126758A CN 104644949 A CN104644949 A CN 104644949A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- medicine
- external application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating osteoproliferation, belonging to the technical field of traditional Chinese medicines. The medicine comprises an oral composition and an external application composition, wherein the oral composition is prepared from the following materials according to a certain weight ratio: radix clematidis, angelica sinensis, Chinese polyphaga, dragon's blood, divaricate saposhnikovia root, juncus effusus, caulis sinomenii, teasel root, radix codonopsis, agrimonia pilosa, cuscuta chinensis, semen euryales, astragalus, peach seed, piper cubeba and common clubmoss herb; and the external application composition is prepared from the following materials according to a certain weight ratio: rhizoma gastrodiae, scorpio, fructus mume, rhizoma drynariae, olibanum, calamitas urinae hominis, safflower, liquorice, futokadsura stem, rhizoma corydalis, rhizoma cyperi, caulis spatholobi, blackend swallowwort root, bombyx batryticatus, costus speciosus and fringed pink. The medicine disclosed by the invention has the effects of dispelling wind and eliminating dampness, promoting blood circulation to remove meridian obstruction and eliminating stagnant blood and relieving pain, and also has the effects of tonifying kidney and strengthening bones, relaxing tendons and activating collaterals and nourishing liver and kidney. Due to compatibility in use, the various medicines are synergistic, and the medicine disclosed by the invention has a good curative effect of treating the osteoproliferation.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of hyperosteogeny, belong to technical field of Chinese medicines.
Background technology
Hyperosteogeny is a kind of person in middle and old age's chronic disease common on Orthopedic Clinical, is a kind of performance of femoral joint degeneration, generally speaking patient chronic arthritis due to joint margins hyperosteogeny caused by.The patient of hyperosteogeny often there will be ankylosis, tired and be attended by pain, and after activity, symptom takes a turn for the better, but after activity aggravation or continuously active, turn again heavy, causes very large obstruction for live and work.Clinical common hyperosteogeny mainly contains hyperosteogeny of cervical vertebra, lumbar vertebra hyperosteogeny and knee joint hyperosteogeny three types.Current doctor trained in Western medicine there is no effective medicine to this disease, often adopts anti symptom treatment, as taken the medicine of some antipyretic-antalgics during pain; Numbness person can select vitamin B group class medicine; Arthroncus has hydrops, and person can give therapy such as local extraction hydrops or partial closure etc.But facts have proved that these Therapeutic Method are all undesirable, just take stopgap measures and do not effect a permanent cure, treatment cost is high, and the state of an illness easily recurs.Primary disease is included in the category of " rheumatism involving the bone " by motherland's medical science, and think that primary disease occurs many due to insufficiency of vital energy and blood, caused by liver and kidney deficiency, wind-cold damp pathogen invades bone network or tumbling down sprain and contusion, trauma bone network, so that stagnation of QI-blood, runs mistake smooth, stagnation of QI and blood may bring about pain.The traditional Chinese medical science, with its distinctive advantage, dialectically from pathology to treat, and has good effect to the treatment of hyperosteogeny.
Summary of the invention
The object of the present invention is to provide a kind of medicine for the treatment of hyperosteogeny, it is high that the treatment of this medicine to hyperosteogeny has curative effect, and short treating period, does not recur more, the advantage that cost is low.
The present invention is by the following technical solutions:
A kind of medicine for the treatment of hyperosteogeny, it is characterized in that, it comprises oral component and external application component, and described oral component is made up of the crude drug of following weight portion: Radix Clematidis 5-10 part, Radix Angelicae Sinensis 10-20 part, Eupolyphaga Seu Steleophaga 4-8 part, Sanguis Draxonis 6-12 part, Radix Saposhnikoviae 10-20 part, Medulla Junci 8-15 part, Caulis Sinomenii 10-20 part, Radix Dipsaci 20-30 part, Radix Codonopsis 20-30 part, Radix Agrimoniae 8-16 part, Semen Cuscutae 10-20 part, Semen Euryales 4-8 part, Radix Astragali 6-15 part, Semen Persicae 15-25 part, Fructus Litseae 10-20 part, Herba Lycopodii 20-30 part;
Described external application component is made up of the crude drug of following weight portion: Rhizoma Gastrodiae 15-25 part, Scorpio 6-15 part, Fructus Mume 10-15 part, Rhizoma Drynariae 20-30 part, Olibanum 10-20 part, calamitas urinae hominis 5-15 part, Flos Carthami 10-20 part, Radix Glycyrrhizae 10-20 part, Caulis Piperis Kadsurae 15-25 part, Rhizoma Corydalis 10-20 part, Rhizoma Cyperi 10-20 part, Caulis Spatholobi 15-25 part, Radix Cynanchi Atrati 6-12 part, Bombyx Batryticatus 4-10 part, Costus speciosus 10-15 part, Herba Dianthi 10-15 part.
Preferably, the medicine of described treatment hyperosteogeny, its oral component is made up of the crude drug of following weight portion: Radix Clematidis 8 parts, Radix Angelicae Sinensis 15 parts, Eupolyphaga Seu Steleophaga 6 parts, Sanguis Draxonis 9 parts, Radix Saposhnikoviae 15 parts, Medulla Junci 12 parts, Caulis Sinomenii 15 parts, Radix Dipsaci 25 parts, Radix Codonopsis 25 parts, Radix Agrimoniae 12 parts, Semen Cuscutae 15 parts, Semen Euryales 6 parts, the Radix Astragali 12 parts, 20 parts, Semen Persicae, Fructus Litseae 15 parts, Herba Lycopodii 25 parts;
Described external application component is made up of the crude drug of following weight portion: 20 parts, Rhizoma Gastrodiae, Scorpio 10 parts, Fructus Mume 12 parts, Rhizoma Drynariae 25 parts, Olibanum 15 parts, calamitas urinae hominis 10 parts, 15 parts, Flos Carthami, 15 parts, Radix Glycyrrhizae, Caulis Piperis Kadsurae 20 parts, Rhizoma Corydalis 15 parts, Rhizoma Cyperi 15 parts, Caulis Spatholobi 20 parts, Radix Cynanchi Atrati 9 parts, Bombyx Batryticatus 8 parts, Costus speciosus 12 parts, Herba Dianthi 12 parts.
The preparation method of the oral component of this medicine is as follows:
(1) take above-mentioned formula ratio material medicine according to quantity, add 800-1000ml cold water soak wherein after 1 hour, first to burn to boiling slow fire boiling again 30 minutes with intense fire, filter to obtain a filtered juice;
(2) continuing to add water 500ml decoction to seething with excitement latter 25 minutes in filtering residue, filtering to obtain secondary filtered juice;
(3) first and second filtered juice merged, heating is concentrated into 300ml.
The preparation method of described external application component is as follows:
(1) formula ratio material medicine is pulverized grind into powder respectively, after crossing 80-100 mesh sieve, mix homogeneously obtains mixed powder;
(2) in mixed powder, add appropriate yellow wine be modulated into pasty medicament and get final product.
The usage of medicine of the present invention and consumption: the present invention's oral component one side is potion, potion on the one, one day twice, respectively take 150ml in 1 hour after meal sooner or later.External application component: get the pasty medicament uniform application made in advance and spread on affected part, according to affected part area Reasonable adjustment drug dose, generally spreading out and being coated with thickness is about 0.5cm, then with medical bandage wrapping (should not be too tight and too loose), within 1 day, changes dressings once.Oral component and external application component simultaneously with the use of, within 10 days, be 1 course for the treatment of, general 2-4 can cure a course for the treatment of.
The pharmacological action of medicine of the present invention is as follows:
Radix Clematidis: acrid in the mouth, salty, warm in nature; Return urinary bladder channel; There is wind-damp dispelling, the effect of the meridian dredging.Radix Angelicae Sinensis: sweet, acrid, warm; Return liver, the heart, spleen channel; There is promoting blood circulation and stopping pain, tonifying blood and regulating menstruation, effect of loosening bowel to relieve constipation.Eupolyphaga Seu Steleophaga: salty, cold; Return Liver Channel; There is removing blood stasis with potent drugs blood, effect of reuniting the fractured tendons and bones.Sanguis Draxonis: sweet, salty is flat; GUIXIN, Liver Channel; There is analgesic therapy of invigorating blood circulation, removing stasis to stop bleeding, effect of expelling pus and promoting granulation.Radix Saposhnikoviae: pungent, sweet, tepor; Return bladder, lung, spleen, Liver Channel; There is expelling pathogenic wind from the body surface, removing dampness to relieve pain, effect of relieving convulsion.Medulla Junci: sweet, light, is slightly cold; GUIXIN, lung, small intestine meridian; There is clearing away heart-fire, effect of diuresis.Caulis Sinomenii: bitter, pungent is flat; Return liver, spleen channel; There is wind-damp dispelling, the meridian dredging, effect of diuresis.Radix Dipsaci: bitter, sweet, pungent; Return liver, kidney channel; There is invigorating the liver and kidney, bone and muscle strengthening, continuous injured, effect of only metrorrhagia.Radix Codonopsis: sweet is flat; Return spleen, lung meridian; There is invigorating middle warmer, QI invigorating, the effect of promoting the production of body fluid.Radix Agrimoniae: pained, dry; Enter lung, liver, spleen channel; There are astringing to arrest bleeding, antiinflammatory, dysentery relieving, removing toxic substances, parasite killing, effect of invigorating vital energy and reinforce the heart.Semen Cuscutae: Xin Gan is flat; Enter liver, kidney channel; There is the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, Gu effect of tire stopping leak.Semen Euryales: sweet, puckery is flat; Return spleen, kidney channel; There is supplementing the kidney to control the nocturnal, spleen reinforcing antidiarrheal, effect of eliminating dampness and arresting leucorrhea.The Radix Astragali: sweet, tepor; Return lung, spleen, liver, kidney channel; There is invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, effect of expelling pus and promoting granulation.Semen Persicae: bitter, sweet, flat; GUIXIN, liver, large intestine channel; There is blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, effect of relieving cough and asthma.Fructus Litseae: pungent, temperature; Return spleen, stomach, kidney, urinary bladder channel; There is warming spleen and stomach for dispelling cold, effect of promoting the circulation of QI to relieve pain.Herba Lycopodii: bitter, micro-pungent, temperature; Liver,spleen,kidney warp; There is expelling wind and removing dampness, effect of relaxing muscles and tendons and activating QI and blood in the collateral.Rhizoma Gastrodiae: sweet, flat; Enter Liver Channel; There is effect of suppressing the hyperactive liver to relieve the wind syndrome relieving convulsion.Scorpio: pungent, flat; Return Liver Channel; There is endogenous wind stopping spasmolytic, removing obstruction in the collateral to relieve pain, effect of dispersing pathogen accumulation.Fructus Mume: sour, puckery is flat; Return liver, spleen, lung, large intestine channel; Have and astringe the lung, astringing intestine to stop diarrhea, promote the production of body fluid, effect of relieving colic caused by ascaris.Rhizoma Drynariae: bitter, temperature; Enter liver, kidney channel; There is the kidney invigorating, invigorate blood circulation, effect of hemostasis.Olibanum: pungent, bitter, temperature; GUIXIN, liver, spleen channel; There is blood-activating and qi-promoting pain relieving, effect of detumescence and promoting granulation.Calamitas urinae hominis: salty, cold; Enter liver, three burnt, urinary bladder channels; There is heat-clearing and toxic substances removing, effect of hemostasis by removing blood stasis.Flos Carthami: pungent, temperature; GUIXIN, Liver Channel; There is promoting blood circulation to restore menstrual flow, effect of eliminating stasis to stop pain.Radix Glycyrrhizae: flat, sweet; Enter spleen, stomach warp; There is invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, effect of coordinating the actions of various ingredients in a prescription.Caulis Piperis Kadsurae: pungent, bitter, tepor; Return Liver Channel; There is wind-damp dispelling, the meridian dredging, effect of stopping numbness pain.Rhizoma Corydalis: temperature, arduous; Enter the heart, spleen, liver, lung meridian; There is promoting blood circulation to remove blood stasis, effect of promoting the circulation of QI pain relieving.Rhizoma Cyperi: pungent, micro-hardship, micro-sweet, flat; Return liver, spleen, tri-jiao channel; There is dispersing the stagnated live-QI to relieve the stagnation of QI, regulating the flow of QI to ease the stomach, effect of menstruction regulating and pain relieving.Caulis Spatholobi: bitter, sweet, temperature; Return liver, kidney channel; There is blood circulation promoting and enriching, menstruction regulating and pain relieving, effect of relaxing muscles and tendons and activating QI and blood in the collateral.Radix Cynanchi Atrati: bitter salty, cold; Enter lung, stomach, kidney channel; There is clearing away heat and cooling blood, inducing diuresis for treating stranguria syndrome, effect of detoxification sore treatment.Bombyx Batryticatus: salty, pungent is flat; Return liver, lung, stomach warp; There is expelling wind for relieving convulsion, effect of dissipating phlegm and resolving masses.Costus speciosus: pungent, sour, is slightly cold; Inlet air, Tu Ta; There is inducing diuresis to remove edema, effect of detoxifying and relieving itching.Herba Dianthi: bitter, cold; GUIXIN, small intestine meridian; There is inducing diuresis for treating stranguria syndrome, effect that removing blood stasis stimulates the menstrual flow.
Each performs its own functions for each herbal medicine above, complement each other, effect of existing expelling wind and removing dampness, promoting blood circulation to remove obstruction in the collateral, eliminating stasis to stop pain, has again effect of invigorating the kidney and strengthening the bones, relaxing muscles and tendons and activating QI and blood in the collateral, nourishing the liver and kidney, each medicine Synergistic after compatibility uses, has good curative effect to the treatment of hyperosteogeny.
Compared with prior art, the invention has the beneficial effects as follows: the medication effect of the treatment hyperosteogeny prepared by the present invention is good, and short treating period, does not recur more, and cost is low.The present invention is used by oral drugs and liniment compatibility simultaneously, and drug effect is through focus place rapidly, and the efficacy of a drug acts on focus lastingly continuously, reaches the effect for the treatment of both the principal and secondary aspects of a disease.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is described in further detail.
Embodiment 1
Treat a medicine for hyperosteogeny, it comprises oral component and external application component:
Oral component is made up of the crude drug of following weight: Radix Clematidis 5g, Radix Angelicae Sinensis 10g, Eupolyphaga Seu Steleophaga 4g, Sanguis Draxonis 6g, Radix Saposhnikoviae 10g, Medulla Junci 8g, Caulis Sinomenii 10g, Radix Dipsaci 20g, Radix Codonopsis 20g, Radix Agrimoniae 8g, Semen Cuscutae 10g, Semen Euryales 4g, Radix Astragali 6g, Semen Persicae 15g, Fructus Litseae 10g, Herba Lycopodii 20g;
External application component is made up of the crude drug of following weight: Rhizoma Gastrodiae 15g, Scorpio 6g, Fructus Mume 10g, Rhizoma Drynariae 20g, Olibanum 10g, calamitas urinae hominis 5g, Flos Carthami 10g, Radix Glycyrrhizae 10g, Caulis Piperis Kadsurae 15g, Rhizoma Corydalis 10g, Rhizoma Cyperi 10g, Caulis Spatholobi 15g, Radix Cynanchi Atrati 6g, Bombyx Batryticatus 4g, Costus speciosus 10g, Herba Dianthi 10g.
In said medicine, the preparation method of oral component is as follows:
(1) take above-mentioned formula ratio material medicine according to quantity, add 800-1000ml cold water soak wherein after 1 hour, first to burn to boiling slow fire boiling again 30 minutes with intense fire, filter to obtain a filtered juice;
(2) continuing to add water 500ml decoction to seething with excitement latter 25 minutes in filtering residue, filtering to obtain secondary filtered juice;
(3) first and second filtered juice merged, heating is concentrated into 300ml.
The preparation method of said medicine external application component is as follows:
(1) formula ratio material medicine is pulverized grind into powder respectively, after crossing 80-100 mesh sieve, mix homogeneously obtains mixed powder;
(2) in mixed powder, add appropriate yellow wine be modulated into pasty medicament and get final product.
Embodiment 2
Treat a medicine for hyperosteogeny, it comprises oral component and external application component:
Oral component is made up of the crude drug of following weight: Radix Clematidis 8g, Radix Angelicae Sinensis 15g, Eupolyphaga Seu Steleophaga 6g, Sanguis Draxonis 9g, Radix Saposhnikoviae 15g, Medulla Junci 12g, Caulis Sinomenii 15g, Radix Dipsaci 25g, Radix Codonopsis 25g, Radix Agrimoniae 12g, Semen Cuscutae 15g, Semen Euryales 6g, Radix Astragali 12g, Semen Persicae 20g, Fructus Litseae 15g, Herba Lycopodii 25g;
External application component is made up of the crude drug of following weight: Rhizoma Gastrodiae 20g, Scorpio 10g, Fructus Mume 12g, Rhizoma Drynariae 25g, Olibanum 15g, calamitas urinae hominis 10g, Flos Carthami 15g, Radix Glycyrrhizae 15g, Caulis Piperis Kadsurae 20g, Rhizoma Corydalis 15g, Rhizoma Cyperi 15g, Caulis Spatholobi 20g, Radix Cynanchi Atrati 9g, Bombyx Batryticatus 8g, Costus speciosus 12g, Herba Dianthi 12g.
The oral component of said medicine and the preparation method of external application component are with embodiment 1.
Embodiment 3
Treat a medicine for hyperosteogeny, it comprises oral component and external application component:
Oral component is made up of the crude drug of following weight: Radix Clematidis 10g, Radix Angelicae Sinensis 20g, Eupolyphaga Seu Steleophaga 8g, Sanguis Draxonis 12g, Radix Saposhnikoviae 20g, Medulla Junci 15g, Caulis Sinomenii 20g, Radix Dipsaci 30g, Radix Codonopsis 30g, Radix Agrimoniae 16g, Semen Cuscutae 20g, Semen Euryales 8g, Radix Astragali 15g, Semen Persicae 25g, Fructus Litseae 20g, Herba Lycopodii 30g;
External application component is made up of the crude drug of following weight: Rhizoma Gastrodiae 25g, Scorpio 15g, Fructus Mume 15g, Rhizoma Drynariae 30g, Olibanum 20g, calamitas urinae hominis 15g, Flos Carthami 20g, Radix Glycyrrhizae 20g, Caulis Piperis Kadsurae 25g, Rhizoma Corydalis 20g, Rhizoma Cyperi 20g, Caulis Spatholobi 25g, Radix Cynanchi Atrati 12g, Bombyx Batryticatus 10g, Costus speciosus 15g, Herba Dianthi 15g.
The oral component of said medicine and the preparation method of external application component are with embodiment 1.
Embodiment 4
Treat a medicine for hyperosteogeny, it comprises oral component and external application component:
Oral component is made up of the crude drug of following weight: Radix Clematidis 6g, Radix Angelicae Sinensis 14g, Eupolyphaga Seu Steleophaga 6g, Sanguis Draxonis 8g, Radix Saposhnikoviae 18g, Medulla Junci 12g, Caulis Sinomenii 12g, Radix Dipsaci 22g, Radix Codonopsis 26g, Radix Agrimoniae 14g, Semen Cuscutae 16g, Semen Euryales 5g, Radix Astragali 10g, Semen Persicae 18g, Fructus Litseae 12g, Herba Lycopodii 22g;
External application component is made up of the crude drug of following weight: Rhizoma Gastrodiae 22g, Scorpio 8g, Fructus Mume 14g, Rhizoma Drynariae 24g, Olibanum 16g, calamitas urinae hominis 12g, Flos Carthami 15g, Radix Glycyrrhizae 14g, Caulis Piperis Kadsurae 22g, Rhizoma Corydalis 12g, Rhizoma Cyperi 16g, Caulis Spatholobi 18g, Radix Cynanchi Atrati 10g, Bombyx Batryticatus 6g, Costus speciosus 13g, Herba Dianthi 12g.
The oral component of said medicine and the preparation method of external application component are with embodiment 1.
Clinical practice example
1. clinical data: random selecting clinical hyperosteogeny case 269 example, wherein man 145 example, female 124 example, the age 32-68 year; Wherein hyperosteogeny of cervical vertebra 123 example, lumbar vertebra hyperosteogeny 79 example, knee joint hyperosteogeny 67 example.
2. diagnostic criteria:
Hyperosteogeny of cervical vertebra: mainly contain nape pain, upper myasthenia of limbs, point numb, lower limb are weak, difficulty in walking, dizziness, Nausea and vomiting, the even clinical symptoms such as blurred vision, tachycardia and dysphagia making a definite diagnosis in conjunction with X-ray.
Lumbar vertebra hyperosteogeny: with the stiff pain of waist or occur the symptoms such as numbness of lower limbs, X-ray visible part patient lumbar physiological-curvature of having a medical check-up is abnormal; Lumbar vertebra both sides muscle has tenderness.
Knee joint hyperosteogeny: side or bilateral joint discomfort, pain and swelling; Movable inconvenient, joint instability, the sound sent when simultaneously having picture to twist with the fingers hair during knee articulation, can teratogenesis or cause paralysis time serious.
3. Therapeutic Method: use the embodiment of the present invention 2 gained medicine to carry out clinical treatment observation, oral component one side is potion, potion on the one, a day twice, sooner or later respectively takes 150ml in 1 hour after meal.External application component: get the pasty medicament uniform application made in advance and spread on affected part, according to affected part area Reasonable adjustment drug dose, generally spreading out and being coated with thickness is about 0.5cm, then with medical bandage wrapping (should not be too tight and too loose), within 1 day, changes dressings once.Oral component and external application component simultaneously with the use of, within 10 days, be 1 course for the treatment of, general 2-4 can cure a course for the treatment of.
4. curative effect determinate standard:
Cure: clinical symptoms, sign all disappear, and patient activity recovers normal, follow up a case by regular visits to more than 1 year without recurrence;
Effective: clinical symptoms, sign alleviate more than half or be clearly better;
Invalid: clinical symptoms, sign are all not improved.
5. therapeutic outcome: the results are shown in following table 1.
| Case load | Cure | Effective | Invalid | Total effective rate % | |
| Hyperosteogeny of cervical vertebra | 123 | 104 | 19 | 1 | 99.2 |
| Lumbar vertebra hyperosteogeny | 79 | 68 | 10 | 1 | 98.7 |
| Knee joint hyperosteogeny | 67 | 55 | 11 | 1 | 98.5 |
As can be seen from the above results, medicine of the present invention all has good therapeutic effect to all kinds of hyperosteogeny patient, and it reaches 99.2% to the treatment total effective rate of hyperosteogeny of cervical vertebra, is a kind of medicine for the treatment of hyperosteogeny well.
Model case
Case 1: Lee, man, 45 years old, patient's waist pain more than ten sky, difficulty of bending over, limitation of activity, companion malaise, X-ray display the 2nd, 3,4 lumbar vertebra hyperosteogeny.After using 1 course for the treatment of of medicine of the present invention, patient pain's symptom obviously alleviates, 1 course for the treatment of of rear continuation after treatment, and patient clinical symptom all disappears, and follows up a case by regular visits to 1 year without recurrence.
Case 2: Dong, man, 32 years old, patient's cervicodynia, movable unfavorable right side aching of the shoulder and arm, forefinger, middle finger are numb, show 5-7 through X-ray and save hyperosteogeny of cervical vertebra, after using 2 courses for the treatment of of medicine of the present invention, patient's numbness of the fingers symptom disappears substantially, and cervical vertebra moving is good, after continuing to strengthen 1 course for the treatment of of treatment, clinical symptoms all disappears, and patient activity freely, follows up a case by regular visits to 2 years without recurrence.
Case 3: grandson so-and-so, man, 65 years old, in more than ten years of patient's double knee joint pain, limitation of activity, can not squat down, go to toilet, upper difficulty downstairs.Check display bilateral knee joint portion mild swelling, local tenderness (+), X-ray film shows: double knee joint gap turn narrow, joint margins hyperosteogeny, and tibia spinous process of tibia comes to a point, and is diagnosed as knee joint hyperosteogeny.Through multi-treatment, DeGrain, by after use 2 courses for the treatment of of Drug therapy of the present invention, patient activity slowly recovers, and goes to toilet, the upper activity such as downstairs can take care of oneself substantially, after 2 courses for the treatment of of rear continuation after treatment, clinical symptoms all disappears, and follows up a case by regular visits to 3 years without recurrence.
Case 4: Wang, female, 60 years old, left and right foot knee joint hyperosteogeny 5 years, arthroncus of knee joints, can not walk 1 year substantially, and during Changes in weather, aggravation, can't take care of oneself.After using 3 courses for the treatment of of medicine of the present invention after being introduced, patient fully recovers, and movablely recovers normal, follows up a case by regular visits to 2 years without recurrence.
Claims (2)
1. treat the medicine of hyperosteogeny for one kind, it is characterized in that, it comprises oral component and external application component, and described oral component is made up of the crude drug of following weight portion: Radix Clematidis 5-10 part, Radix Angelicae Sinensis 10-20 part, Eupolyphaga Seu Steleophaga 4-8 part, Sanguis Draxonis 6-12 part, Radix Saposhnikoviae 10-20 part, Medulla Junci 8-15 part, Caulis Sinomenii 10-20 part, Radix Dipsaci 20-30 part, Radix Codonopsis 20-30 part, Radix Agrimoniae 8-16 part, Semen Cuscutae 10-20 part, Semen Euryales 4-8 part, Radix Astragali 6-15 part, Semen Persicae 15-25 part, Fructus Litseae 10-20 part, Herba Lycopodii 20-30 part;
Described external application component is made up of the crude drug of following weight portion: Rhizoma Gastrodiae 15-25 part, Scorpio 6-15 part, Fructus Mume 10-15 part, Rhizoma Drynariae 20-30 part, Olibanum 10-20 part, calamitas urinae hominis 5-15 part, Flos Carthami 10-20 part, Radix Glycyrrhizae 10-20 part, Caulis Piperis Kadsurae 15-25 part, Rhizoma Corydalis 10-20 part, Rhizoma Cyperi 10-20 part, Caulis Spatholobi 15-25 part, Radix Cynanchi Atrati 6-12 part, Bombyx Batryticatus 4-10 part, Costus speciosus 10-15 part, Herba Dianthi 10-15 part.
2. the medicine for the treatment of hyperosteogeny according to claim 1, it is characterized in that, described oral component is made up of the crude drug of following weight portion: Radix Clematidis 8 parts, Radix Angelicae Sinensis 15 parts, Eupolyphaga Seu Steleophaga 6 parts, Sanguis Draxonis 9 parts, Radix Saposhnikoviae 15 parts, Medulla Junci 12 parts, Caulis Sinomenii 15 parts, Radix Dipsaci 25 parts, Radix Codonopsis 25 parts, Radix Agrimoniae 12 parts, Semen Cuscutae 15 parts, Semen Euryales 6 parts, the Radix Astragali 12 parts, 20 parts, Semen Persicae, Fructus Litseae 15 parts, Herba Lycopodii 25 parts;
Described external application component is made up of the crude drug of following weight portion: 20 parts, Rhizoma Gastrodiae, Scorpio 10 parts, Fructus Mume 12 parts, Rhizoma Drynariae 25 parts, Olibanum 15 parts, calamitas urinae hominis 10 parts, 15 parts, Flos Carthami, 15 parts, Radix Glycyrrhizae, Caulis Piperis Kadsurae 20 parts, Rhizoma Corydalis 15 parts, Rhizoma Cyperi 15 parts, Caulis Spatholobi 20 parts, Radix Cynanchi Atrati 9 parts, Bombyx Batryticatus 8 parts, Costus speciosus 12 parts, Herba Dianthi 12 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510126758.4A CN104644949A (en) | 2015-03-23 | 2015-03-23 | Medicine for treating osteoproliferation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510126758.4A CN104644949A (en) | 2015-03-23 | 2015-03-23 | Medicine for treating osteoproliferation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104644949A true CN104644949A (en) | 2015-05-27 |
Family
ID=53236919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510126758.4A Pending CN104644949A (en) | 2015-03-23 | 2015-03-23 | Medicine for treating osteoproliferation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104644949A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1214932A (en) * | 1998-10-28 | 1999-04-28 | 孙德培 | Traditional Chinese medicine composition for curing hyperosteogeny |
| CN1795905A (en) * | 2004-12-23 | 2006-07-05 | 张生全 | Medication for treating hyperosteogeny and complicating disease |
| CN102552816A (en) * | 2012-02-15 | 2012-07-11 | 范云贤 | Plaster for treating pain and preparation method thereof |
| CN104258285A (en) * | 2014-09-28 | 2015-01-07 | 夏征梅 | Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof |
-
2015
- 2015-03-23 CN CN201510126758.4A patent/CN104644949A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1214932A (en) * | 1998-10-28 | 1999-04-28 | 孙德培 | Traditional Chinese medicine composition for curing hyperosteogeny |
| CN1795905A (en) * | 2004-12-23 | 2006-07-05 | 张生全 | Medication for treating hyperosteogeny and complicating disease |
| CN102552816A (en) * | 2012-02-15 | 2012-07-11 | 范云贤 | Plaster for treating pain and preparation method thereof |
| CN104258285A (en) * | 2014-09-28 | 2015-01-07 | 夏征梅 | Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101912572B (en) | Multi-effect external plaster | |
| CN104958484A (en) | traditional Chinese medicine unguent for promoting blood circulation to remove meridian obstruction and preparing method of traditional Chinese medicine unguent | |
| CN104367911A (en) | Traditional Chinese medicinal composition for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof | |
| CN101766773A (en) | Traditional Chinese medicine formula for treating heel pain | |
| CN112168872A (en) | Traditional Chinese medicine hot moxibustion ointment and preparation method thereof | |
| CN102008610B (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN104083457A (en) | Orthopaedic medicinal liquor for treating qi deficiency and body weakness type lumbar muscle strain and preparation method | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN102961483B (en) | Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof | |
| CN102949680B (en) | Medicinal liquor for treating cervical spondylosis and preparation method thereof | |
| CN103479819B (en) | The Chinese prescription of traditional Chinese medicine fumigating moxibustion therapy treatment rheumatoid arthritis | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN102335246B (en) | Composition of Chinese medicinal herbs for treating bone spurs | |
| CN101690797B (en) | Traditional Chinese medicine for treating rheumatism and rheumatoid diseases | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN104758527A (en) | Traditional Chinese medicine composition for treating pain in waists and legs | |
| CN104815017A (en) | Traditional Chinese medicine ointment for treating osteoproliferation and preparation method of ointment | |
| CN104173932A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN103736013B (en) | One treats phthisical Chinese medicine | |
| CN102949507A (en) | Traditional Chinese medicine lotion for treating lumbocrural pain and preparation method thereof | |
| CN102416053A (en) | Medicinal moxaroll for treating sciatica and preparation method thereof | |
| CN104644949A (en) | Medicine for treating osteoproliferation | |
| CN105250856A (en) | Chinese herb composition for treating climacteric syndrome | |
| CN104873847A (en) | Traditional Chinese medicine lotion for alleviating local swelling and pain caused by soft tissue injury and preparation method of traditional Chinese medicine lotion | |
| CN117562944A (en) | Medicine for treating lumbar paralysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150527 |